Pascal Coorevits

Prof. Dr. Pascal Coorevits


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2024 in JMIR Medical Informatics
Verified
Journal Article
Open access
JDJens Declerck
Jens Declerck
DKDipak Kalra
Dipak Kalra
RSRobert Vander Stichele
Robert Vander Stichele
PCPascal Coorevits
Pascal Coorevits
Background: Health care has not reached the full potential of the secondary use of health data because of—among other issues—concerns about the quality of the data being used. The shift toward digital health has led to an increase in the volume of health data. However, this increase in quantity has not been matched by a proportional improvement in the quality of health data. Objective: This review aims to offer a comprehensive overview of the existing frameworks for data quality dimensions and assessment methods for the secondary use of health data. In addition, it aims to consolidate the results into a unified framework. Methods: A review of reviews was conducted including reviews describing frameworks of data quality dimensions and their assessment methods, specifically from a secondary use perspective. Reviews were excluded if they were not related to the health care ecosystem, lacked relevant information related to our research objective, and were published in languages other than English. Results: A total of 22 reviews were included, comprising 22 frameworks, with 23 different terms for dimensions, and 62 definitions of dimensions. All dimensions were mapped toward the data quality framework of the European Institute for Innovation through Health Data. In total, 8 reviews mentioned 38 different assessment methods, pertaining to 31 definitions of the dimensions. Conclusions: The findings in this review revealed a lack of consensus in the literature regarding the terminology, definitions, and assessment methods for data quality dimensions. This creates ambiguity and difficulties in developing specific assessment methods. This study goes a step further by assigning all observed definitions to a consolidated framework of 9 data quality dimensions.

31 March 2011 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
KBKatie Gw Bouche
Katie Gw Bouche
OVOlivier Vanovermeire
Olivier Vanovermeire
VSVeerle K Stevens
Veerle K Stevens
PCPascal Coorevits
Pascal Coorevits
JCJacques J Caemaert
Jacques J Caemaert
LDLieven AG Danneels
Lieven AG Danneels
No consensus exists on how rehabilitation programs for lumbar discectomy patients with persistent complaints after surgery should be composed. A better understanding of normal and abnormal postoperative trunk muscle condition might help direct the treatment goals.

4 August 2021 in JMIR Medical Informatics
Verified
Journal Article
Open access
HAHannelore Aerts
Hannelore Aerts
DKDipak Kalra
Dipak Kalra
CSCarlos Sáez
Carlos Sáez
JRJuan Manuel Ramírez-Anguita
Juan Manuel Ramírez-Anguita
MMMiguel Mayer
Miguel Mayer
PCPascal Coorevits
Pascal Coorevits
Background: There is increasing recognition that health care providers need to focus attention, and be judged against, the impact they have on the health outcomes experienced by patients. The measurement of health outcomes as a routine part of clinical documentation is probably the only scalable way of collecting outcomes evidence, since secondary data collection is expensive and error-prone. However, there is uncertainty about whether routinely collected clinical data within electronic health record (EHR) systems includes the data most relevant to measuring and comparing outcomes and if those items are collected to a good enough data quality to be relied upon for outcomes assessment, since several studies have pointed out significant issues regarding EHR data availability and quality. Objective: In this paper, we first describe a practical approach to data quality assessment of health outcomes, based on a literature review of existing frameworks for quality assessment of health data and multistakeholder consultation. Adopting this approach, we performed a pilot study on a subset of 21 International Consortium for Health Outcomes Measurement (ICHOM) outcomes data items from patients with congestive heart failure. Methods: All available registries compatible with the diagnosis of heart failure within an EHR data repository of a general hospital (142,345 visits and 12,503 patients) were extracted and mapped to the ICHOM format. We focused our pilot assessment on 5 commonly used data quality dimensions: completeness, correctness, consistency, uniqueness, and temporal stability. Results: We found high scores (>95%) for the consistency, completeness, and uniqueness dimensions. Temporal stability analyses showed some changes over time in the reported use of medication to treat heart failure, as well as in the recording of past medical conditions. Finally, the investigation of data correctness suggested several issues concerning the characterization of missing data values. Many of these issues appear to be introduced while mapping the IMASIS-2 relational database contents to the ICHOM format, as the latter requires a level of detail that is not explicitly available in the coded data of an EHR. Conclusions: Overall, results of this pilot study revealed good data quality for the subset of heart failure outcomes collected at the Hospital del Mar. Nevertheless, some important data errors were identified that were caused by fundamentally different data collection practices in routine clinical care versus research, for which the ICHOM standard set was originally developed. To truly examine to what extent hospitals today are able to routinely collect the evidence of their success in achieving good health outcomes, future research would benefit from performing more extensive data quality assessments, including all data items from the ICHOM standards set and across multiple hospitals.

1 October 2005 in Journal of Electromyography and Kinesiology
Verified
Journal Article
Closed access
PCPascal Coorevits
Pascal Coorevits
LDLieven AG Danneels
Lieven AG Danneels
HRH. Ramon
H. Ramon
RAR. Van Audekercke
R. Van Audekercke
DCD.C. Cambier
D.C. Cambier
GVG.G. Vanderstraeten
G.G. Vanderstraeten

1 December 2014 in International Journal of Rehabilitation Research
Verified
Journal Article
Open access
BRBarbara Van Ruymbeke
Barbara Van Ruymbeke
JBJan Boone
Jan Boone
PCPascal Coorevits
Pascal Coorevits
GVGuy Vanderstraeten
Guy Vanderstraeten
JBJan Bourgois
Jan Bourgois
The aim of this study was to analyse muscle activity and subjectively perceived exertion [rating of perceived exertion (RPE)] during whole-body vibration (WBV) in breast cancer survivors. Twenty breast cancer survivors and 20 healthy controls performed isometric squats on a vibration platform. RPE and muscle activity (surface electromyography) of the rectus femoris, vastus medialis, biceps femoris, tibialis anterior and gastrocnemius were recorded under the following conditions: nonvibration (0 Hz) and vibration (20-30-40-50 Hz) conditions. No significant differences were found between groups with regard to muscle activity (P=0.471) and RPE (P=0.629). Only for vastus medialis was muscle activity higher at 20 and 30 Hz compared with 40 and 50 Hz (P<0.05). RPE increased with increasing vibration frequency; however, no difference was found between 20 and 30 Hz (P=0.088). WBV at 20 and 30 Hz revealed lower subjectively perceived exertion and the highest muscle activity and therefore provide the optimal modalities for WBV in breast cancer survivors.

18 September 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JGJoachim De Groote
Joachim De Groote
CRCaro Roten
Caro Roten
EFElizaveta Fomenko
Elizaveta Fomenko
PCPascal Coorevits
Pascal Coorevits
AHAndré Harth
André Harth
YDYves Depaepe
Yves Depaepe
Background/Objectives: Knee osteoarthritis (OA) is a major cause of pain and functional disability worldwide, leading to a growing interest in more durable and less invasive therapies. Micro-fragmented adipose tissue (MFAT) injections have emerged as a promising frontier in regenerative therapies using mesenchymal stem cells (MSCs). This study assessed the safety and effectiveness of MFAT injections for symptomatic knee OA while investigating the duration of treatment effects. Methods: This longitudinal study screened patients with symptomatic Kellgren-Lawrence (KL) grade II-IV knee OA who received single-dose MFAT injections. Outcomes were assessed using the Knee injury and Osteoarthritis Outcome Score (KOOS) subscales at baseline, 3, 6, and 12 months. A linear mixed effects model was performed to explore how age, BMI, sex, and OA severity influence outcomes. Results: Among 39 evaluable patients, mean baseline KOOS was 46.5 (SD 18.1). KOOS scores improved significantly across all subscales, peaking at six months and remaining higher than baseline at 12 months. Improvements exceeded clinically meaningful thresholds, including KL grades IV. Female patients reported significantly worse overall outcomes than male patients (p < 0.05). Minor self-limiting synovitis was reported in 18% of cases, and no severe adverse events were observed. Conclusions: MFAT infiltration may represent a safe, minimally invasive option to improve symptoms and delay surgery in patients with knee OA, including those with advanced disease. These findings highlight the potential role of MFAT as part of the treatment algorithm for knee OA, although strategies to sustain long-term benefits and confirmatory trials are needed.